The ability of outcome measures to detect change over time is critical fbr
their usefulness in clinical trials. Two concepts are applied in the assess
ment of evaluative instruments: We endorse the recommendation that a distin
ction be made between sensitivity and responsiveness. Sensitivity to change
refers to the capacity of instruments to measure change statistically. Sen
sitivity statistics relate the magnitude of observed change to some measure
of variablity and are essentially signal-to-noise ratios. Responsiveness a
ddresses the detection of clinically relevant change. The methodology is st
ill evolving but a common approach has been to correlate the observed chang
e in scores with external standards that are believed to indicate clinical
relevance (e.g., physician- or patient-based transition scales).
Sensitivity to change and responsiveness of SLE activity indices have been
addressed in a small number of studies. These indicate that the most widely
used systems (SLEDAI. SLAM, BILAG) are sensitive to change although the av
ailable evidence does not allow preference for one instrument over the othe
rs. Little research has been done on the responsiveness of these measures.
This article reviews the methodological concepts in measuring clinical chan
ge and summarizes reports on sensitivity and responsiveness of lupus activi
ty scores.